Results 31 to 40 of about 883,208 (316)
Атеротромбоз, 2016 Restenosis is a complication of percutaneous coronary interventions which results in the destabilization of coronary heart disease. Presents a clinical case of detection of restenosis using stress Echocardiography one year after percutaneous coronary ...
M. A. Elkanova +5 more
doaj +1 more source
BMC Medicine, 2012 Background The benefit of the coronary collateral circulation (natural bypass network) on survival is well established. However, data derived from smaller studies indicates that coronary collaterals may increase the risk for restenosis after percutaneous
Meier Pascal +8 more
doaj +1 more source
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching [PDF]
, 2012 Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial.
Angelo Guglielmotti +12 more
core +3 more sources
Journal of the Renin-Angiotensin-Aldosterone System, 2015 Objective: Previous case-control studies on the relationship between the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphisms and coronary restenosis did not reach the same conclusion.
Haiwei Miao, H. Gong
semanticscholar +1 more source
Кардиоваскулярная терапия и профилактика, 2016 Aim. To study the significance of clinical parameters and cardiovascular risk factors (CVR) for restenosis development at long terms after percutaneous coronary intervention (PCI) as a possible displaying of neoatherosclerosis development (NA).Material ...
V. P. Mazaev +2 more
doaj +1 more source
Restenosis following coronary angioplasty
Clinical Cardiology, 1991 AbstractRestenosis is the most important problem limiting the success of coronary angioplasty. Clinically, restenosis is seen in approximately one‐third of patients undergoing percutaneous transluminal coronary angioplasty. Several clinical and angiographic risk factors have been identified which may contribute to the development of restenosis ...
S P, Karas, E C, Santoian, M B, Gravanis
openaire +2 more sources
The Hybrid Approach to Intervention of Chronic Total Occlusions [PDF]
, 2015 The "hybrid" approach to chronic total occlusion (CTO) percutaneous coronary intervention (PCI) was developed to provide guidance on optimal crossing strategy selection.
Banerjee, S +6 more
core +1 more source
Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
The Egyptian Heart Journal, 2012 Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry +2 more
doaj +1 more source
Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement. [PDF]
PLoS ONE, 2010 Restenosis remains the main complication of balloon angioplasty and/or stent implantation. Preclinical testing of new pharmacologic agents preventing restenosis largely rely on porcine models, where restenosis is assessed after endothelial abrasion of ...
Anne Braun +7 more
doaj +1 more source
Excimer Laser-Assisted Angioplasty for In-Stent Restenosis of the Right Coronary Artery in a Diabetic Patient: A Complex Revascularization Case. [PDF]
Clin Case RepSharma V, Devasia T, Jawanjal M.
europepmc +3 more sources